(1-(5-Hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone
CAS: 335161-21-2
Ref. 3D-KNA16121
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Produktinformation
AB-FUBINACA is a synthetic cannabinoid that is an agonist of the cannabinoid receptors. It is used in scientific research to study the endocannabinoid system, as well as for its potential application in treating neurological disorders such as epilepsy and multiple sclerosis. AB-FUBINACA binds to the CB1 receptor, which inhibits adenylate cyclase and lowers cAMP levels. This results in reduced activity of protein kinase A (PKA), which may play a role in seizure generation or epileptogenesis. The compound has been shown to be effective against the symptoms of Parkinson's disease, including tremors and postural instability. AB-FUBINACA also has analgesic properties and can be used to treat chronic pain syndromes such as fibromyalgia, rheumatoid arthritis, and neuropathic pain.
AB-FUBINACA has been detected in urine samples using GC/MS following chromatographic separation with acetonitrile as the mobile
Chemische Eigenschaften
Technische Anfrage zu: 3D-KNA16121 (1-(5-Hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
